Trademark: 79222989
Status Date
Tuesday, December 11, 2018
Registration Number
5624714
Registration Date
Tuesday, December 11, 2018
Filing Date
Thursday, April 27, 2017
Published for Opposition
Tuesday, September 25, 2018
41 Providing educational, training and mentoring services concerning the causes, prevention, detection, diagnosis, and treatment of diseases through conferences, seminars and written materials disseminated in connection therewith
9 Downloadable electronic educational and professional publications, namely, newsletters, fact sheets, and brochures about a biomedical and scientific research facility; downloadable electronic educational and professional podcasts and webcasts featuring information about biomedical and scientific research on human health and human diseases
16 Printed educational and professional publications, namely, newsletters, fact sheets, and brochures about biomedical and scientific research and information about biomedical and scientific research on human health and human diseases
36 Charitable fund raising; charitable fundraising collections; organisation of collections in the nature of charitable fundraising; charitable services, namely, provision of funding for research, education, prevention, diagnosis and treatment of illnesses and human diseases; financial grant services, namely, providing grants for research, education, prevention, diagnosis, and treatment of illnesses and human diseases; provision of funding for charities in the nature of philanthropic services concerning monetary donations; charitable services, namely, provision of funding for medical trials; charitable services, namely, provision of funding for educational and research posts; information and advisory services relating to all the aforesaid; intellectual property venture fund development and formation services for others enabling inventors of new technology to secure appropriate funding for continued technological development; technology transfer services, namely, financial asset management in the nature of managing revenue from partnered or developed intellectual property
35 Promoting research in the field of human health and human diseases through the support and coordination of research projects conducted by universities, hospitals, research foundations and businesses; business consultation services in the nature of providing advisory, consultancy and information services in the field of commercialisation of products and services by identifying routes to market for research; compilation of scientific, medical and clinical information into computer databases
45 Legal services; licensing of technology, namely, patent licensing; licensing and intellectual property services in relation to technology transfer services, namely, consulting in the field of intellectual property
44 Pharmaceutical treatment diagnostics in the nature of medical and pharmaceutical consultation; medical services; advice on medical information relating to alleviation, diagnosis, prevention and treatment of illnesses and human diseases
42 Scientific, medical and clinical research services; scientific research and analysis in the field of biotechnology; scientific research and analysis in the field of biochemistry; scientific research and analysis in the field of biology; conducting clinical trials for others; data mining; data security consultancy services; data encryption services; database design and development; maintenance of computer software for databases; mathematical modelling services; scientific and technological services, namely, scientific research and analysis in the field of bioinformatics; drug discovery services; laboratory research in the field of medicine; computer programming and software design services; consultancy services relating to all of the foregoing; scientific research and development in the field of medical technology; research on the development and adaptation of health technology and health-related outcomes associated with implementation of health technology; clinical research services, namely, collection, calibration, analysis and reporting of data in connection with clinical trials; conducting clinical trials for others for diagnostic tests and for pharmaceutical preparations; providing temporary use of non-downloadable web-based computer software in the fields of medicine and biotechnology for data integration, exchange, and analysis in the nature of a collaborative research management platform; providing biomedical and scientific information via a global internet web site related to the field of human health and human diseases; technology transfer services, namely, new product design and development services; scientific research and development; product development; antibody humanisation services, namely, antibody engineering in the nature of antibody research and development services; biopharmaceutical product development; biologic assay product development; medical research, namely, preclinical research; clinical research in the fields of genetic disorders and infectious diseases; consulting services for others in the design and planning of project management of clinical trials; testing and inspection of pharmaceuticals in the nature of pharmacovigilance, namely, monitoring the effects of medical drugs after they have been licensed for use
Jan 19, 2024
New Representative At Ib Received
Dec 11, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Apr 12, 2019
Final Decision Transaction Processed By Ib
Mar 21, 2019
Final Disposition Notice Sent To Ib
Mar 21, 2019
Final Disposition Processed
Mar 11, 2019
Final Disposition Notice Created, To Be Sent To Ib
Dec 11, 2018
Registered-Principal Register
Sep 25, 2018
Official Gazette Publication Confirmation E-Mailed
Sep 25, 2018
Published For Opposition
Sep 21, 2018
Notification Processed By Ib
Sep 5, 2018
Notification Of Possible Opposition Sent To Ib
Sep 5, 2018
Notification Of Notice Of Publication E-Mailed
Sep 5, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 24, 2018
Change Of Name/Address Rec'd From Ib
Aug 16, 2018
Approved For Pub - Principal Register
Aug 15, 2018
Examiner's Amendment Entered
Aug 15, 2018
Notification Of Examiners Amendment E-Mailed
Aug 15, 2018
Examiners Amendment E-Mailed
Aug 15, 2018
Examiners Amendment -Written
Jul 31, 2018
Teas/Email Correspondence Entered
Jul 31, 2018
Correspondence Received In Law Office
Jul 24, 2018
Assigned To Lie
Jul 10, 2018
Teas Change Of Correspondence Received
Jul 10, 2018
Teas Response To Office Action Received
Jul 5, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 5, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 27, 2018
Refusal Processed By Ib
Jan 18, 2018
New Representative At Ib Received
Jan 11, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Jan 11, 2018
Refusal Processed By Mpu
Dec 22, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Dec 22, 2017
Application Filing Receipt Mailed
Dec 21, 2017
Non-Final Action Written
Dec 18, 2017
Assigned To Examiner
Dec 18, 2017
New Application Office Supplied Data Entered
Dec 14, 2017
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
